Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of ‘depression due to multiple sclerosis’

Brain, Behavior, and Immunity

Volumn 16, Issue 5, 2002, Pages 533-543

  Pollak, Y ^a   Orion, E ^a   Goshen, I ^a   Ovadia, H ^b   Yirmiya, R ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ACUTE PHASE PROTEIN; DESIPRAMINE; GAMMA INTERFERON; IMIPRAMINE; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2; INTERLEUKIN 6; LOFEPRAMINE; MOCLOBEMIDE; MONOAMINE OXIDASE A INHIBITOR; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; BEHAVIOR; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNOREACTIVITY; MULTIPLE SCLEROSIS; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RELAPSE; REMISSION; SEROTONIN BRAIN LEVEL; SEX DIFFERENCE;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CYTOKINES; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMIPRAMINE; INFLAMMATION; MICE; MULTIPLE SCLEROSIS; SEROTONIN; SEX FACTORS;

EID: 0036432013     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-1591(02)00010-7     Document Type: Article

References (78)

1. Anisman, H., & Merali, Z. (1999). Anhedonic and anxiogenic effects of cytokine exposure. Adv. Exp. Med. Biol., 46, 199-233.
2. Aubert, A., & Dantzer, R. (1998). Effects of lipopolysaccharide on taste reactivity in rats. Neuroimmunomodulation, 5, 3.
3. Austin, M. P., Ross, M., Murray, C., O'Carroll, R. E., Ebmeier, K. P., & Goodwin, G. M. (1992). Cognitive function in major depression. J. Affect. Disord., 25, 21-30.
4. Avitsur, R., & Yirmiya, R. (1999). The immunobiology of sexual behavior: Gender differences in the suppression of sexual activity during illness. Pharmacol. Biochem. Behav., 64, 787-796.
5. Barak, Y., Ur, E., & Achiron, A. (1999). Moclobemide treatment in multiple sclerosis patients with comorbid depression. J. Neuropsychiatry Clin. Neurosci., 11, 271-273.
6. Capuron, L., Lamarque, D., Dantzer, R., & Goodall, G. (1999). Attentional and mnemonic deficits associated with infectious disease in humans. Psychol. Med., 29, 291-297.
7. Capuron, L., Ravaud, A., & Dantzer, R. (2000). Early depressive symptoms in cancer patients receiving interleukin-2 and/or interferon alpha-2b therapy. J. Clin. Oncol., 18, 2143-2151.
8. Castanon, N., Bluthé, R. M., & Dantzer, R. (2000). Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1β in the rat. Psychopharmacology, 154, 50-60.
9. Cavallo, M. G., Pozzini, P., & Thorpe, R. (1993). Cytokines and autoimmunity. Clin. Exp. Immunol., 96, 1-7.
10. Clark, D. C., vonAmmon Cavanaugh, S., & Gibbons, R. D. (1983). The core symptoms of depression in medical and psychiatric patients. J. Nerv. Ment. Dis., 171, 705-713.
11. Connor, T. J., & Leonard, B. E. (1998). Depression, stress and immunological activation: The role of cytokines in depressive disorders. Life Sci., 62, 583-606.
12. Cross-Mellor, S. K., Kent, W. D., Ossenkopp, K. P., & Kavaliers, M. (1999). Differential effects of lipopolysaccharide and cholecystokinin on sucrose intake and palatability. Am. J. Physiol., 277, R705-R715.
13. Dantzer, R. (2001). Cytokine-induced sickness behavior: Where do we stand? Brain Behav. Immunity, 15, 7-24.
14. Dantzer, R., Wollman, E. E., Vitkovic, L., & Yirmiya, R. (1999). Cytokines and depression: Fortuitous or causative associations? Mol. Psychiatry, 4, 328-332.
15. del Rey, A., Klusman, I., & Besedovsky, H. O. (1998). Cytokines mediate protective simulation of glucocorticoid output during autoimmunity: Involvement of IL-1. Am. J. Physiol., 275, R1146-R1151.
16. Dieperink, E., Willenbring, M., & Ho, S. B. (2000). Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review. Am. J. Psychiatry, 157, 867-876.
17. DSM-IV. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th Ed.). Washington, DC: American Psychiatric Association.
18. Du-Clos, T. W., Mold, C., Paterson, P. Y., Alroy, J., & Gewurz, H. (1981). Localization of C-reactive protein in inflammatory lesions of experimental allergic encephalomyelitis. Clin. Exp. Immunol., 43, 565-573.
19. Eng, L. F., Ghirnikar, R. S., & Ling Lee, Y. (1996). Inflammation in EAE: Role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem. Res., 21, 511-525.
20. Fassbender, K., Schmidt, R., Mossner, R., Kischka, U., Kuhnen, J., Schwartz, A., & Hennerici, M. (1998). Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: Association with cerebral inflammation. Arch. Neurol., 55, 66-72.
21. Faustman, W. O., Faull, K. F., Whiteford, H. A., Borchert, C., & Csernasky, J. G. (1990). CSF 5-HIAA, serum cortisol, and age differentially predict vegetative and cognitive symptoms in depression. Biol. Psychiatry, 27, 311-318.
22. Foley, F. W., Traugott, U., LaRocca, N. G., Smith, C. R., Perlman, K. R., Caruso, L. S., & Scheinberg, L. C. (1992). A prospective study of depression and immune dysregulation in multiple sclerosis. Arch. Neurol., 49, 238-244.
23. Gavard, J. A., Lustman, P. J., & Clouse, R. E. (1993). Prevalence of depression in adults with diabetes. Diabetes Care, 16, 1167-1178.
24. Gijbels, K., Engelborghs, S., & De Dein, P. P. (2000). Experimental autoimmune encephalomyelitis: An animal model for multiple sclerosis. Neurosci. Res. Communications, 26, 193-206.
25. Hickie, I., & Lloyd, A. (1995). Are cytokines associated with neuropsychiatric syndromes in humans? Int. J. Immunopharmacol., 17, 677-683.
26. Hosaka, T., Aoki, T., Watanabe, T., Okuyama, T., & Kurosawa, H. (1999). Comorbidity of depression among physically ill patients and its effect on the length of hospital stay. Psychiatry Clin. Neurosci., 53, 491-495.
27. Hunter, N., Weston, K. M., & Bowern, N. A. (1991). Suppression of experimental allergic encephalomyelitis by alpha 2-macroglobulin. Immunology, 73, 58-63.
28. Hutchinson, G. A., Nehall, J. E., & Simeon, D. T. (1996). Psychiatric disorders in systemic lupus erythematosus. West Indian Med. J., 45, 48-50.
29. Joffe, R. T., Lippert, G. P., Gray, T. A., Sawa, G., & Horvath, A. (1987). Mood disorder and multiple sclerosis. Arch. Neurol., 44, 376-378.
30. Kennedy, M. K., Torrance, D. S., Picha, K. S., & Mohler, K. M. (1992). Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol., 149, 2496-2505.
31. Krenger, W., Kabiersch, A., & Honegger, C. G. (1989). Monoamines and related substances in brainstem and spinal cord of Lewis rats during the attack and recovery of experimental autoimmune encephalomyelitis. Brain Res., 491, 374-378.
32. Kubera, M., Symbirtsev, A., Basta-Kaim, A., Borycz, J., Roman, A., Papp, M., & Claesson, M. (1996). Effect of chronic treatment with imipramine on interleukin-1 and interleukin-2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression. Pol. J. Pharmacol., 48, 503-506.
33. MacPhee, I. A. M., Antoni, F. A., & Mason, W. D. (1989). Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med., 169, 431-445.
34. Maes, M. (1995). Evidence for an immune response in major depression: A review and hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiatry, 19, 11-38.
35. Maj, M. (1996). Depressive syndromes and symptoms in subjects with human immunodeficiency virus (HIV) infection. Br. J. Psychiatry, 168, 117-122.
36. Maier, S. F., & Watkins, L. R. (1995). Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res., 695, 279-282.
37. Meyers, C. A. (1999). Mood and cognitive disorders in cancer patients receiving cytokine therapy. Adv. Exp. Med. Biol., 46, 75-81.
38. Minden, S. L., Orav, J., & Reich, P. (1987). Depression in multiple sclerosis. Gen. Hosp. Psychiatry, 9, 426-434.
39. Morag, M., Yirmiya, R., Lerer, B., & Morag, A. (1998). Influence of socioeconomic status on behavioral, emotional, and cognitive effects of rubella vaccination: A prospective, double blind study. Psychoneuroendocrinology, 23, 337-351.
40. Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manantunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alfa. New Engl. J. Med., 344, 961-966.
41. Okuda, Y., Nakatsuji, Y., Fujimura, H., Esumi, H., Ogura, T., Yanagihara, T., & Sakoda, S. (1995). Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol., 62, 103-112.
42. Patten, S. B., & Metz, L. M. (1997). Depression is multiple sclerosis. Psychother. Psychosom., 66, 286-292.
43. Pincus, T., Griffith, J., Pearce, S., & Isenberg, D. (1996). Prevalence of self-reported depression in patients with rheumatoid arthritis. Br. J. Rheumatol., 35, 879-883.
44. Plotsky, P. M., Owens, M. J., & Nemeroff, C. B. (1998). Psychoneuroendocrinology of depression: Hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. North Am., 21, 293-307.
45. Pollak, Y., Ovadia, H., Goshen, I., Gurevich, R., Monsa, K., Avitzur, R., & Yirmiya, R. (2000). Behavioral aspects of autoimmune encephalomyelitis. J. Neuroimmunol., 104, 31-36.
46. Puri, B. K., Bydder, G. M., Chaudhuri, K. R., Al-Saffar, B. Y., Curati, W. L., White, S. J., Mitchell, L., Hajnal, J. V., & Horrobin, D. F. (2001). MRI changes in multiple sclerosis following treatment with lofepramine and L-phenylalanine. Neuroreport, 12, 1821-1824.
47. Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., & Pollmächer, T. (2001). Endotoxin-induced emotional and cognitive disturbances in healthy volunteers are associated with increased plasma levels of cytokines and cortisol. Arch. Gen. Psychiatry, 58, 445-452.
48. Risch, S. C., & Nemeroff, C. B. (1992). Neurochemical alterations of serotonergic neural system in depression. J. Clin. Psychiatry, 53, 3-7.
49. Robinson, R. G. (1997). Neuropsychiatric consequences of stroke. Annu. Rev. Med., 48, 217-229.
50. Rodin, G., & Voshart, K. (1986). Depression in the medically ill: An overview. Am. J. Psychiatry, 143, 696-705.
51. Sadovnick, A. D., Remick, R. A., Alien, J., Swartz, E., Lee, I. M. L., Eisen, K., Farquhar, R., Hashimoto, S. A., Hooge, J., Kastrukoff, L. F., Morrison, W., Nelson, J., Ogar, J., & Paty, D. W. (1996). Depression and multiple sclerosis. Neurology, 46, 628-632.
52. Schiffer, R. B., & Babigian, H. M. (1984). Behavioral disorders in multiple sclerosis, temporal lobe epilepsy, and amyotrophic lateral sclerosis: An epidemiological study. Arch. Neurol., 41, 1067-1069.
53. Schiffer, R. B., Caine, E. D., Bamford, K. A., & Levy, S. (1983). Depressive episodes in patients with multiple sclerosis. Am. J. Psychiatry, 140, 1498-1500.
54. Schiffer, R. B., Weitkamp, L. R., Wineman, N. M., & Guttormsen, S. (1988). Multiple sclerosis and affective disorder. Family history, sex, and HLA-DR antigens. Arch. Neurol., 45, 1345-1348.
55. Schiffer, R. B., & Wineman, N. M. (1990). Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am. J. Psychiatry, 147, 1493-1497.
56. Schubert, D. S. P., & Foliart, R. H. (1993). Increased depression in multiple sclerosis patients: A meta analysis. Psychosomatics, 34, 124-130.
57. Scott, T. F., Nussbaum, P., McConnell, H., & Brill, P. (1995). Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale. Neurol. Res., 17, 421-422.
58. Shen, Y., Connor, T. J., Nolan, Y., Kelly, J. P., & Leonard, B. E. (1999). Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sci., 17, 1773-1786.
59. Smith, A. P., Thomas, M., Brockman, P., Kent, J., & Nicholson, K. G. (1993). Effect of influenza B virus infection on human performance. Br. Med. J., 306, 760-761.
60. Smith, A. P., Tyrrell, D. A. J., Al-Nakib, W., Coyle, K. B., Donovan, C. B., Higgins, P. G., & Willman, J. S. (1988). The effects of experimentally induced respiratory virus infections on performance. Psychol. Med., 18, 65-71.
61. Smith, A. P., Tyrrell, D. A. J., & Barrow, G. I. (1992). Mood and experimentally induced respiratory virus infections and illness. Psychol. Health, 6, 205-212.
62. Smith Begolka, W., & Miller, S. D. (1998). Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis. Res. Immunol., 149, 771-781.
63. Song, C., & Leonard, B. E. (1995). The effects of olfactory bulbectomy in the rat, alone or in combination with antidepressants and endogenous factors, or immune function. Hum. Psychopharmacol., 10, 7-18.
64. Steinman, L. (1999). Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron, 24, 511-514.
65. Sullivan, M. J., Weinshenker, B., Mikail, S., & Edgley, K. (1995). Depression before and after diagnosis of multiple sclerosis. Mult. Scler., 1, 104-108.
66. Szechtman, H., Sakic, B., & Denburg, J. A. (1997). Behaviour of MRL mice: An animal model of disturbed behaviour in systemic autoimmune disease. Lupus, 6, 223-229.
67. Watkins, L. R., & Maier, S. F. (1999). Implications of immune-to-brain communication for sickness and pain. Proc. Natl. Acad. Sci. USA, 6, 7710-7713.
68. White, S. R., Samathanam, G. K., Bowker, R. M., & Wessendorf, M. W. (1990). Damage to bulbospinal serotonin, tyrosine hydroxylase, and TRH-containing axons occurs early in the development of experimental allergic encephalomyelitis in rats. J. Neurosci. Res., 27, 89-98.
69. White, S. R., White, F. P., Barnes, C. D., & Albright, J. F. (1973). Increased shock sensitivity in rats with experimental allergic encephalomyelitis and reversal by 5-hydroxytryptophan. Brain Res., 58, 251-254.
70. Whitlock, F. A., & Siskind, M. M. (1980). Depression as a major symptom of multiple sclerosis. J. Neural. Neurosurg. Psychiatry, 43, 861-865.
71. Willner, P. (1994). Animal models of depression. In J. A. den Boer, & J. M. Sitsen (Eds.), Handbook of Depression and Anxiety (pp. 291-316). New York: Marcel Dekker Inc.
72. Willner, P. (1997). Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology, 134, 319-329.
73. Yehuda, S., Rabinovitz, S., Mostofsky, D. I., Huberman, M., & Sredni, B. (1997). Essential fatty acid preparation improves biochemical and cognitive functions in experimental allergic encephalomyelitis rats. Eur. J. Pharmacol., 328, 23-29.
74. Yirmiya, R. (1996). Endotoxin produces a depressive-like syndrome in rats. Brain Res., 711, 163-174.
75. Yirmiya, R. (1997). Behavioral and psychological effects of immune activation: Implications for 'depression due to a general medical condition'. Curr. Opin. Psychiatry, 10, 470-476.
76. Yirmiya, R., Pollak, Y., Barak, O., Avitsur, R., Ovadia, H., Bette, M., Weihe, E., & Weidenfeld, J. (2001). Effects of antidepressant drugs on the behavioral and psychological responses to lipopolisaccharide (LPS) in Rodents. Neuropsychopharmacology, 24, 531-544.
77. Yirmiya, R., Pollak, Y., Morag, M., Reichenberg, A., Barak, O., Avitsur, R., Shavit, Y., Ovadia, H., Weidenfeld, J., Morag, A., Newman, M. E., & Pollmächer, T. (2000). Illness, cytokines and depression. Ann. NY Acad. Sci., 917, 478-487.
78. Yirmiya, R., Weidenfeld, J., Pollak, Y., Morag, M., Morag, A., Avitsur, R., Barak, O., Reichenberg, A., Cohen, E., Shavit, Y., & Ovadia, H. (1999). Cytokines, 'depression due to a general medical condition', and antidepressant drugs. Adv. Exp. Med. Biol., 46, 283-316.